Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients.

Source:http://linkedlifedata.com/resource/pubmed/id/19709689

Download in:

View as

General Info

PMID
19709689